Report Examines PEPFAR Transition in South Africa
January 16, 2014
Health GAP and its partners on Wednesday released a report that "looks at the PEPFAR 'transition' in [South Africa] -- moving from 'directly supporting' over one million people on ARV treatment in South Africa in early 2011 to a near complete withdrawal from support for 'direct services.' ... The report finds that the political transition -- toward increased South African ownership and innovative models of shared governance for U.S. funds -- is yielding important benefits ... [and] recommends an urgent course correction for PEPFAR South Africa -- tracing patients and health workers while considering a more measured approach in the country," according to press release. The report accompanies an article forthcoming in the Journal of Acquired Immune Deficiency Syndromes (1/15).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)